替考拉宁结构式
|
常用名 | 替考拉宁 | 英文名 | Teicoplanin |
|---|---|---|---|---|
| CAS号 | 61036-62-2 | 分子量 | 2526.73 | |
| 密度 | 1.7±0.1 g/cm3 | 沸点 | N/A | |
| 分子式 | C130H175Cl2N9O37R6 | 熔点 | N/A | |
| MSDS | 中文版 美版 | 闪点 | N/A |
替考拉宁用途Teicoplanin是一种半合成的糖肽抗生素, 预防和治疗革兰氏阳性菌引起的严重感染, 包括耐Methicillin的金黄色葡萄球菌和肠球菌。 |
| 中文名 | 替考拉宁 |
|---|---|
| 英文名 | Telicoplanin |
| 英文别名 | 更多 |
| 密度 | 1.7±0.1 g/cm3 |
|---|---|
| 分子式 | C130H175Cl2N9O37R6 |
| 分子量 | 2526.73 |
| PSA | 662.41000 |
| LogP | 0.40 |
| InChIKey | BJNLLBUOHPVGFT-CAYRISATSA-N |
| SMILES | CCCCCCCCCC(=O)NC1C(Oc2c3cc4cc2Oc2ccc(cc2Cl)C(OC2OC(CO)C(O)C(O)C2NC(C)=O)C2NC(=O)C(NC(=O)C4NC(=O)C4NC(=O)C(Cc5ccc(c(Cl)c5)O3)NC(=O)C(N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(OC4OC(CO)C(O)C(O)C4O)cc(O)cc3C(C(=O)O)NC2=O)OC(CO)C(O)C1O |
| 折射率 | 1.754 |
| 储存条件 | 2-8℃ |
| 个人防护装备 | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| 危害码 (欧洲) | Xi |
| 危险品运输编码 | NONH for all modes of transport |
| RTECS号 | WY1559000 |
|
Role of extra-cellular fatty acids in vancomycin induced biofilm formation by vancomycin resistant Staphylococcus aureus.
Pak. J. Pharm. Sci. 26(2) , 383-9, (2013) In the present study a vancomycin resistant Staphylococcus aureus (S. aureus) (VRSA) (Labeled as CP2) was isolated from the blood of a post-operative cardiac patient is described. It harbors a plasmid... |
|
|
A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity.
Sci. Transl. Med. 7 , 290ra89, (2015) Currently, no approved therapeutics exist to treat or prevent infections induced by Ebola viruses, and recent events have demonstrated an urgent need for rapid discovery of new treatments. Repurposing... |
|
|
Once-weekly dalbavancin versus daily conventional therapy for skin infection.
N. Engl. J. Med. 370(23) , 2169-79, (2014) Dalbavancin, a lipoglycopeptide antibiotic agent that is active against gram-positive pathogens, has a long plasma half-life, allowing for once-weekly dosing. DISCOVER 1 and DISCOVER 2 were identicall... |
| teichomycin |
| TEICOPLANIN |
| (1S,2R,19R,22R,34S,37R,40R,52R)-2-[(2-Acetamido-2-deoxy-β-D-glucopyranosyl)oxy]-22-amino-5,15-dichloro-64-{[2-(decanoylamino)-2-deoxy-β-D-glucopyranosyl]oxy}-26,31,44,49-tetrahydroxy-47-(α-D -mannopyranosyloxy)-21,35,38,54,56,59-hexaoxo-7,13,28-trioxa-20,36,39,53,55,58-hexaazaundecacyclo[38.14.2.2.2.2.1.1.1.1.0.0]hexahexaconta-3,
 5,8(64),9,11,14,16,23(61),24,26,29(60),30,32 |
| TEICOPLANIN,JP |
| Tagocid |
| TeicoplaninSodium |
| 8327a |
| TEIC |
| Teicoplanin(sterile,non-sterile) |
| antibiotic8327a |
| Teocoplanin |